GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,411.00p
   
  • Change Today:
      16.20p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,067.39m
  • Volume: 452,608
  • Market Cap: 57,391m
  • RiskGrade: 129

GSK Overview

UK-based GSK Plc is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GSK Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,186.00 3,525.00 111.80p 14.8 1.6 +9% 80.00p 4.8%
31-Dec-18 30,821.00 4,800.00 119.40p 15.6 2.2 +7% 80.00p 4.3%
31-Dec-19 33,754.00 6,221.00 123.90p 17.9 4.5 +4% 80.00p 3.6%
31-Dec-20 34,099.00 6,968.00 1.17p 1,433.9 n/a -99% 0.81p 0.0%
31-Dec-21 34,114.00 5,442.00 113.20p 17.7 0.0 +9,576% 80.00p 4.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 29,068.89 6,904.77 135.32p 10.3 0.5 +20% 58.14p 4.2%
31-Dec-23 29,479.58 7,821.67 147.84p 9.4 1.0 +9% 56.24p 4.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
17-Nov-22 Buy Dividends Hal Barron 1,373.07p 104 1,427.99
17-Nov-22 Buy Dividends Hal Barron 1,373.07p 5,354 73,513.97
09-Nov-22 Buy Emma Walmsley 1,396.38p 8 111.71

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,411.00p
Change Today 16.20p
% Change 1.16 %
52 Week High 2,263.00
52 Week Low 1,296.00
Volume 452,608
Shares Issued 4,067.39m
Market Cap 57,391m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
55.4% below the market average55.4% below the market average55.4% below the market average55.4% below the market average55.4% below the market average
17.46% below the sector average17.46% below the sector average17.46% below the sector average17.46% below the sector average17.46% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 7
Buy 0
Neutral 14
Sell 0
Strong Sell 1
Total 22
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 17-Nov-22 18-Aug-22
Paid 12-Jan-23 06-Oct-22
Amount 13.75p 16.25p

Trades for 29-Nov-2022

Time Volume / Share Price
10:00 88 @ 1,411.00p
10:00 72 @ 1,411.00p
10:00 67 @ 1,411.00p
10:00 71 @ 1,411.00p
10:00 69 @ 1,411.00p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page